关注
Patrik Fazio
标题
引用次数
引用次数
年份
Encoding of human action in Broca's area
P Fazio, A Cantagallo, L Craighero, A D’ausilio, AC Roy, T Pozzo, ...
Brain 132 (7), 1980-1988, 2009
3342009
A2A adenosine receptor overexpression and functionality, as well as TNF‐α levels, correlate with motor symptoms in Parkinson's disease
K Varani, F Vincenzi, A Tosi, S Gessi, I Casetta, G Granieri, P Fazio, ...
The FASEB journal 24 (2), 587-598, 2010
1452010
Gender differences in health-related quality of life in multiple sclerosis
I Casetta, T Riise, M Wamme Nortvedt, NT Economou, R De Gennaro, ...
Multiple Sclerosis Journal 15 (11), 1339-1346, 2009
1332009
Nigrostriatal dopamine transporter availability in early Parkinson's disease
P Fazio, P Svenningsson, Z Cselényi, C Halldin, L Farde, A Varrone
Movement Disorders 33 (4), 592-599, 2018
962018
The first case history of multiple sclerosis: Augustus d’Esté (1794–1848)
AM Landtblom, P Fazio, S Fredrikson, E Granieri
Neurological sciences 31, 29-33, 2010
812010
Feasibility of clinical magnetoencephalography (MEG) functional mapping in the presence of dental artefacts
A Hillebrand, P Fazio, JC De Munck, BW Van Dijk
Clinical Neurophysiology 124 (1), 107-113, 2013
672013
Gait measures with a triaxial accelerometer among patients with neurological impairment
P Fazio, G Granieri, I Casetta, E Cesnik, S Mazzacane, P Caliandro, ...
Neurological Sciences 34, 435-440, 2013
622013
Altered resting state effective connectivity in long-standing vegetative state patients: an EEG study
G Varotto, P Fazio, DR Sebastiano, D Duran, L D’Incerti, E Parati, D Sattin, ...
Clinical Neurophysiology 125 (1), 63-68, 2014
572014
In vivo and in vitro characterization of a novel MAO-B inhibitor radioligand, 18F-labeled deuterated fluorodeprenyl
S Nag, P Fazio, L Lehmann, G Kettschau, T Heinrich, A Thiele, ...
Journal of Nuclear Medicine 57 (2), 315-320, 2016
552016
Quantitative analysis of 18F-(E)-N-(3-iodoprop-2-enyl)-2β-carbofluoroethoxy-3β-(4′-methyl-phenyl) nortropane binding to the dopamine transporter in Parkinson disease
P Fazio, P Svenningsson, A Forsberg, EG Jönsson, N Amini, R Nakao, ...
Journal of Nuclear Medicine 56 (5), 714-720, 2015
552015
Incidence and prognosis of stroke in young adults: a population-based study in Ferrara, Italy
E Groppo, R De Gennaro, G Granieri, P Fazio, E Cesnik, E Granieri, ...
Neurological sciences 33, 53-58, 2012
542012
The Lombrosian prejudice in medicine. The case of epilepsy. Epileptic psychosis. Epilepsy and aggressiveness
E Granieri, P Fazio
Neurological sciences 33, 173-192, 2012
432012
Multiple sclerosis in the Republic of San Marino: a prevalence and incidence study
E Granieri, C Monaldini, R De Gennaro, S Guttmann, M Volpini, M Stumpo, ...
Multiple Sclerosis Journal 14 (3), 325-329, 2008
382008
Music and emotion: An EEG connectivity study in patients with disorders of consciousness
G Varotto, P Fazio, DR Sebastiano, G Avanzini, S Franceschetti, ...
2012 Annual International Conference of the IEEE Engineering in Medicine and …, 2012
302012
Positron emission tomography measurement of brain MAO-B inhibition in patients with Alzheimer’s disease and elderly controls after oral administration of sembragiline
S Sturm, A Forsberg, S Nave, P Stenkrona, N Seneca, A Varrone, ...
European journal of nuclear medicine and molecular imaging 44, 382-391, 2017
282017
PET molecular imaging of phosphodiesterase 10A: An early biomarker of Huntington's disease progression
P Fazio, CJ Fitzer‐Attas, L Mrzljak, J Bronzova, S Nag, JH Warner, ...
Movement Disorders 35 (4), 606-615, 2020
272020
Optimal acquisition time window and simplified quantification of dopamine transporter availability using 18F-FE-PE2I in healthy controls and Parkinson disease patients
I Sonni, P Fazio, M Schain, C Halldin, P Svenningsson, L Farde, ...
Journal of Nuclear Medicine 57 (10), 1529-1534, 2016
262016
In vivo measurement of PDE10A enzyme occupancy by positron emission tomography (PET) following single oral dose administration of PF-02545920 in healthy male subjects
M Delnomdedieu, A Forsberg, A Ogden, P Fazio, CR Yu, P Stenkrona, ...
Neuropharmacology 117, 171-181, 2017
252017
Patterns of age related changes for phosphodiesterase type-10A in comparison with dopamine D2/3 receptors and sub-cortical volumes in the human basal ganglia: A PET study with …
P Fazio, M Schain, L Mrzljak, N Amini, S Nag, N Al-Tawil, CJ Fitzer-Attas, ...
Neuroimage 152, 330-339, 2017
242017
In vivo visualization of pituitary dopaminergic receptors by iodine-123 methoxybenzamide (IBZM) correlates with sensitivity to dopamine agonists in two patients with …
A Scillitani, F Dicembrino, P Di Fazio, PP Vettori, V D'angelo, T Scarabino, ...
The Journal of Clinical Endocrinology & Metabolism 80 (8), 2523-2525, 1995
221995
系统目前无法执行此操作,请稍后再试。
文章 1–20